DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Opiant Pharmaceuticals Q4 EPS $0.2 Up From $(2.49) YoY, Sales $7.7M Beat $7.63M Estimate

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $0.2 per share. This is a 108.03 percent increase over losses of $(2.49) per share from the same period last year. The company reported quarterly sales

Benzinga · 03/04/2020 21:10

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $0.2 per share. This is a 108.03 percent increase over losses of $(2.49) per share from the same period last year. The company reported quarterly sales of $7.7 million which beat the analyst consensus estimate of $7.63 million by 0.92 percent. This is a 60.42 percent increase over sales of $4.8 million the same period last year.